Question 1

What is NAXITAMAB used for?

Accepted Answer

NAXITAMAB (brand name DANYELZA) is a Other indicated for 1 INDICATIONS AND USAGE DANYELZA is indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), minor response.

Question 2

How does NAXITAMAB work?

Accepted Answer

NAXITAMAB works through the following mechanism: 12.1 Mechanism of Action Naxitamab-gqgk binds to the glycolipid GD2. GD2 is a disialoganglioside that is overexpressed on neuroblastoma cells and other cells of neuroectodermal origin, including the central nervous system and peripheral nerves. In vitro, naxitamab-gqgk was able to bind to cell surface GD2 and induce complement dependent cytotoxicity (CDC) and antibody dependent cell-mediated cytotoxicity (ADCC)..

Question 3

What are the most common side effects of NAXITAMAB?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for NAXITAMAB. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is NAXITAMAB the same as DANYELZA?

Accepted Answer

DANYELZA is a brand name for NAXITAMAB. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

NAXITAMAB

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations